Recuren Plus Jock Itch Cream

Manufacturer
REGENEREN PLUS LTD | Jiangxi Zhongletang Pharmaceuticals Co., Ltd.
Effective date
2026-05-08
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:56:30

Label at a glance#

ProductRecuren Plus Jock Itch Cream
Active ingredientMICONAZOLE NITRATE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

MICONAZOLE NITRATE 2%

OTC - PURPOSE SECTION

Antifungal

INDICATIONS & USAGE SECTION

For the effective treatment of jock itch (tinea cruris), athlete’s foot (tinea pedis), ringworm (tinea corporis), and other common fungal skin infections.

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

On children under 3 years of age

OTHER SAFETY INFORMATION

Store in a cool, dry place

OTC - STOP USE SECTION

Irritation occurs or if there is no improvement within 4 weeks.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help immediately.

OTC - WHEN USING SECTION

Avoid contact with the eyes

OTC - ASK DOCTOR SECTION

You have concerns about skin irritation or if symptoms persist beyond 4 weeks.

DOSAGE & ADMINISTRATION SECTION

1. Apply a small amount of cream to the affected area 2–3 times daily. 2. Make sure the skin is clean and dry before application. 3. For first-time users, perform a patch test on a small area of skin to check for sensitivity.

INACTIVE INGREDIENT SECTION

Aqua (Water), Lavandula Angustifolia (Lavender) Oil, Eugenia Caryophyllus (Clove) Leaf/Bud Oil, Aloe Barbadensis Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Chamomilla Recutita (Matricaria) Flower Extract, Eucalyptus Globulus Leaf Oil, Tocopherol, Borneol, Menthol, Stearic Acid, Petrolatum, Paraffinum Liquidum, Glycerin, Triethanolamine.

OTC - QUESTIONS SECTION

Please contact the email: service@recurenplus.co.uk

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998483miconazole nitrate 2 % Topical CreamPSN4
998483miconazole nitrate 20 MG/ML Topical CreamSCD4
998483miconazole nitrate 2 % Topical CreamSY4

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MICONAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3a55f4fb-5aec-4c88-0ff7-4d608ad4866aProduct name120140508
5b9a7965-36d2-8412-dcaf-f76a65411611Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87014-004-01Recuren Plus Jock Itch Cream30 g in 1 CARTONCREAM304

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87014-00487014-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32026-02-12monthly-update2026-06-03 17:56:29
22025-12-08monthly-update2026-06-03 17:45:48

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Recuren Plus Jock Itch CreamMICONAZOLE NITRATE 2%REGENEREN PLUS LTD450dab4d-168a-60b8-e063-6394a90ab3032026-05-08WarningsExact identifier
ndc (package): 87014-004-01
ndc (product): 87014-004
ndc11 (package): 87014000401
spl id: 515180f0-952a-4e7d-e063-6394a90a349e
spl set id: 450dab4d-168a-60b8-e063-6394a90ab303

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.